Anricofen is developed by The First Affiliated Hospital of Xinxiang Medical College.

Last reviewed 2026-04-19 · How we verify

Anricofen

The First Affiliated Hospital of Xinxiang Medical College · Phase 1 active Small molecule

At a glance

Generic name	Anricofen
Sponsor	The First Affiliated Hospital of Xinxiang Medical College
Modality	Small molecule
Therapeutic area	Other
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Randomized Controlled Trial on the Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Anricofen CI brief — competitive landscape report
Anricofen updates RSS · CI watch RSS
The First Affiliated Hospital of Xinxiang Medical College portfolio CI